Status:
ACTIVE_NOT_RECRUITING
Mammography Screening With Artificial Intelligence (MASAI)
Lead Sponsor:
Region Skane
Collaborating Sponsors:
Unilabs
Norwegian Institute of Public Health
Conditions:
Breast Cancer
Eligibility:
FEMALE
40-74 years
Phase:
NA
Brief Summary
The purpose of this randomized controlled trial is to assess whether AI can improve the efficacy of mammography screening, by adapting single and double reading based on AI derived cancer-risk scores ...
Detailed Description
European guidelines recommend that mammography exams in breast cancer screening are read by two breast radiologists to ensure a high sensitivity. Double reading is, however, resource demanding and sti...
Eligibility Criteria
Inclusion
- Women eligible for population-based mammography screening.
Exclusion
- None.
Key Trial Info
Start Date :
April 12 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 7 2025
Estimated Enrollment :
100000 Patients enrolled
Trial Details
Trial ID
NCT04838756
Start Date
April 12 2021
End Date
May 7 2025
Last Update
April 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mammography Unit, Unilabs/Skane University Hospital
Malmo, Skåne County, Sweden, 20550